Hubei Guangji Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 688.169 million compared to CNY 731.340 million a year ago. Operating income was CNY 96.837 million compared to CNY 98.870 million a year ago. Net income was CNY 74.647 million compared to CNY 86.943 million a year ago. Basic earnings per share from continuing operations was CNY 0.2232 compared to CNY 0.2841 a year ago.